Canopy Growth Forecast: Bleak Future for Cannabis Giant Amid Mounting Financial Woes
Toronto-based financial firm Eight Capital has delivered a damning verdict on cannabis producer Canopy Growth, giving the Canadian operator a $0 price target and stating that valuing the company as a going concern is no longer appropriate. In a research report titled “Last Puffs of the Roach,” Eight Capital’s analyst Ty Collin points out critical issues with Canopy’s financial standing:
Firstly, Canopy has less than 12 months of cash runway left, leaving it in a precarious position. Secondly, the company lacks viable financing alternatives, limiting its options to recover. Lastly, the firm faces significant ongoing losses without a clear path to profitability, raising concerns about its long-term sustainability. As a result, Eight Capital has opted for an asset-based/breakup valuation, which has led them to conclude that Canopy’s net asset value is effectively zero after accounting for its substantial debts.
Collin’s report highlights the volatile environment for Canadian cannabis companies, with the recent bankruptcy of leading cannabis retailer Fire & Flower and the distressed sale of Hexo to Tilray serving as cautionary examples. This goes to show that no cannabis company, no matter its size or prominence, is immune to the challenges facing the industry.
In Canopy’s fiscal year ending March 31, the company reported a staggering net loss of 3.3 billion Canadian dollars ($2.5 billion) and expressed doubts about its ability to continue as a “going concern.” The situation worsens when we examine the recent quarter’s performance, as Canopy burned CA$143 million of cash, failing to curb its cash consumption despite prior attempts to streamline costs.
Eight Capital believes that Canopy’s financial reserves could be completely depleted within the next year if drastic interventions and substantial cash cost reductions are not implemented – a scenario they consider unlikely given the company’s track record. The management’s current plan of action seems inadequate and potentially too late to salvage the situation.
Earlier this week, Canopy announced the completion of all conversions pursuant to the $100 million (132 million Canadian dollars) senior unsecured convertible debentures sold to an institutional investor in February 2023. Although Canopy claims to have implemented numerous balance sheet actions to strengthen its financial position since the beginning of fiscal 2023, including a business-transformation plan, these efforts may not be sufficient to turn the tide.
In its bid to address its financial challenges, Canopy has been selling off assets, including its facility in Modesto, California, on June 29. The company has sold five facilities, generating proceeds of CA$81 million since April 1, 2023. However, even with these sales, Canopy anticipates generating a total of CA$150 million from facility sales by Sept. 30, 2023, which may still fall short of resolving its financial woes.
Fitch’s downgrade of Canopy’s rating to CCC- in October 2022 raised red flags, indicating substantial credit risk and a very low margin for safety. The agency’s warning of a real possibility of default further exacerbates the uncertainty surrounding the company’s future.
As Canopy Growth’s shares continue to trade as WEED on the Toronto Stock Exchange and CGC on the Nasdaq, investors are closely watching the developments in the hopes of a potential turnaround, but the forecast remains undeniably bleak for the once-promising cannabis giant.
